Law360, New York (December 13, 2011, 7:12 PM ET) -- The U.S. Food and Drug Administration will not face a contempt of court claim after it decided not to allow over-the-counter sales of generic emergency contraceptive drugs to women under 17, a New York federal judge ruled Tuesday.
Reproductive groups, led by the Center for Reproductive Rights, had sought to hold the FDA in contempt after it dragged its feet on a March 2009 court order directing the FDA to reconsider the groups’ petition to allow OTC sales of contraceptive Plan B and its generics to...
FDA Ducks Contempt Claim After Nixing OTC Contraceptives
To view the full article, take a free trial now.
